NanoGel

NanoGel Technologies was a biotechnology company focused on the development of advanced nanomedicines using a proprietary polymer-based drug delivery platform. The company's core technology, developed by co-founder Dr. Alexander Kabanov, utilized cross-linked polymer networks (nanogels) to encapsulate and deliver therapeutic agents, including small molecules and oligonucleotides. These nanogels were designed to improve the solubility, stability, and targeted delivery of drugs, with a particular emphasis on overcoming the blood-brain barrier and reversing multi-drug resistance in cancer. While the company was active in the mid-2000s and early 2010s, its primary focus was on pre-clinical research and establishing proof-of-concept for its delivery systems. The technology has since been widely cited in academic literature and has influenced subsequent developments in the field of nanomedicine.